Back to Search Start Over

Design and testing of a humanized porcine donor for xenotransplantation.

Authors :
Anand RP
Layer JV
Heja D
Hirose T
Lassiter G
Firl DJ
Paragas VB
Akkad A
Chhangawala S
Colvin RB
Ernst RJ
Esch N
Getchell K
Griffin AK
Guo X
Hall KC
Hamilton P
Kalekar LA
Kan Y
Karadagi A
Li F
Low SC
Matheson R
Nehring C
Otsuka R
Pandelakis M
Policastro RA
Pols R
Queiroz L
Rosales IA
Serkin WT
Stiede K
Tomosugi T
Xue Y
Zentner GE
Angeles-Albores D
Chris Chao J
Crabtree JN
Harken S
Hinkle N
Lemos T
Li M
Pantano L
Stevens D
Subedar OD
Tan X
Yin S
Anwar IJ
Aufhauser D
Capuano S
Kaufman DB
Knechtle SJ
Kwun J
Shanmuganayagam D
Markmann JF
Church GM
Curtis M
Kawai T
Youd ME
Qin W
Source :
Nature [Nature] 2023 Oct; Vol. 622 (7982), pp. 393-401. Date of Electronic Publication: 2023 Oct 11.
Publication Year :
2023

Abstract

Recent human decedent model studies <superscript>1,2</superscript> and compassionate xenograft use <superscript>3</superscript> have explored the promise of porcine organs for human transplantation. To proceed to human studies, a clinically ready porcine donor must be engineered and its xenograft successfully tested in nonhuman primates. Here we describe the design, creation and long-term life-supporting function of kidney grafts from a genetically engineered porcine donor transplanted into a cynomolgus monkey model. The porcine donor was engineered to carry 69 genomic edits, eliminating glycan antigens, overexpressing human transgenes and inactivating porcine endogenous retroviruses. In vitro functional analyses showed that the edited kidney endothelial cells modulated inflammation to an extent that was indistinguishable from that of human endothelial cells, suggesting that these edited cells acquired a high level of human immune compatibility. When transplanted into cynomolgus monkeys, the kidneys with three glycan antigen knockouts alone experienced poor graft survival, whereas those with glycan antigen knockouts and human transgene expression demonstrated significantly longer survival time, suggesting the benefit of human transgene expression in vivo. These results show that preclinical studies of renal xenotransplantation could be successfully conducted in nonhuman primates and bring us closer to clinical trials of genetically engineered porcine renal grafts.<br /> (© 2023. The Author(s).)

Details

Language :
English
ISSN :
1476-4687
Volume :
622
Issue :
7982
Database :
MEDLINE
Journal :
Nature
Publication Type :
Academic Journal
Accession number :
37821590
Full Text :
https://doi.org/10.1038/s41586-023-06594-4